Vladislav Mileyko
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
-
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Cancer Genomics and Diagnostics 11
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 4
- PARP inhibition in cancer therapy 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Maxim Ivanov (15 shared papers)Ancha Baranova (6 shared papers)Paul T. Spellman (1 shared paper)Timothy Butler (1 shared paper)К. К. Лактионов (3 shared papers)В. В. Бредер (3 shared papers)М. Yu. Fedyanin (5 shared papers)Olga E. Bryzgunova (1 shared paper)
- Journals
- Journal of Translational Medicine (2 papers)World Journal of Oncology (1 paper)ESMO Open (1 paper)Nucleic Acids Research (1 paper)BMC Genomics (1 paper)
- Partner nations
- RussiaUnited StatesItaly
In The Last Decade
Vladislav Mileyko
19 papers receiving 282 citations
Peers
Comparison fields: 5 of 38
- Cancer Research 177
- Oncology 70
- Pathology and Forensic Medicine 40
- Molecular Biology 127
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Vladislav Mileyko
This map shows the geographic impact of Vladislav Mileyko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladislav Mileyko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladislav Mileyko more than expected).
Fields of papers citing papers by Vladislav Mileyko
This network shows the impact of papers produced by Vladislav Mileyko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladislav Mileyko. The network helps show where Vladislav Mileyko may publish in the future.
Co-authors
The 25 scholars most cited alongside Vladislav Mileyko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 154 | |
| 2 | 2023 | 26 | |
| 3 | 2017 | 22 | |
| 4 | 2010 | 17 | |
| 5 | 2019 | 15 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 8 | |
| 8 | 2019 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 5 | |
| 11 | 2024 | 3 | |
| 12 | 2016 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 |
About Vladislav Mileyko
Vladislav Mileyko is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 19 papers that have together received 283 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (4 papers), PARP inhibition in cancer therapy (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Genomic variations and chromosomal abnormalities (2 papers) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Cancer Research (177 citations), Oncology (70 citations), Pathology and Forensic Medicine (40 citations), Molecular Biology (127 citations) and Pulmonary and Respiratory Medicine (48 citations). Vladislav Mileyko has collaborated with scholars based in Russia, United States and Italy. Frequent co-authors include Maxim Ivanov, Ancha Baranova, Paul T. Spellman, Timothy Butler, К. К. Лактионов, В. В. Бредер, М. Yu. Fedyanin, Olga E. Bryzgunova, Pavel P. Laktionov and Evgeny S. Morozkin. Their work appears in journals such as Journal of Translational Medicine, World Journal of Oncology, ESMO Open, Nucleic Acids Research and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.